全文获取类型
收费全文 | 472篇 |
免费 | 28篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 40篇 |
妇产科学 | 19篇 |
基础医学 | 67篇 |
口腔科学 | 40篇 |
临床医学 | 47篇 |
内科学 | 49篇 |
神经病学 | 48篇 |
特种医学 | 20篇 |
外科学 | 27篇 |
综合类 | 17篇 |
预防医学 | 31篇 |
眼科学 | 22篇 |
药学 | 13篇 |
中国医学 | 1篇 |
肿瘤学 | 60篇 |
出版年
2022年 | 4篇 |
2021年 | 3篇 |
2020年 | 3篇 |
2019年 | 6篇 |
2018年 | 5篇 |
2017年 | 6篇 |
2016年 | 10篇 |
2015年 | 11篇 |
2014年 | 7篇 |
2013年 | 15篇 |
2012年 | 22篇 |
2011年 | 17篇 |
2010年 | 17篇 |
2009年 | 14篇 |
2008年 | 13篇 |
2007年 | 27篇 |
2006年 | 22篇 |
2005年 | 20篇 |
2004年 | 21篇 |
2003年 | 22篇 |
2002年 | 18篇 |
2001年 | 12篇 |
2000年 | 8篇 |
1999年 | 13篇 |
1998年 | 15篇 |
1997年 | 9篇 |
1996年 | 14篇 |
1995年 | 8篇 |
1994年 | 6篇 |
1993年 | 8篇 |
1992年 | 6篇 |
1991年 | 6篇 |
1990年 | 5篇 |
1989年 | 9篇 |
1988年 | 10篇 |
1986年 | 5篇 |
1985年 | 4篇 |
1984年 | 6篇 |
1983年 | 5篇 |
1981年 | 4篇 |
1979年 | 3篇 |
1976年 | 3篇 |
1975年 | 7篇 |
1974年 | 4篇 |
1973年 | 13篇 |
1972年 | 6篇 |
1971年 | 5篇 |
1970年 | 6篇 |
1969年 | 3篇 |
1962年 | 2篇 |
排序方式: 共有502条查询结果,搜索用时 0 毫秒
81.
Background: Burning mouth syndrome (BMS) is characterized by a spontaneous burning pain in the oral mucosa without known organic cause or standardized treatment. The aims of this study were to assess and compare the efficacy of clonazepam and diazepam in relieving the symptoms associated with BMS and evaluate for which patients this treatment might be effective by correlating treatment efficacy with underlying psychological status. Methods: The medical records of BMS patients attending an oral medicine private practice (1999–2004) were reviewed. The patients were then contacted and asked to complete a short questionnaire regarding their response to diazepam/clonazepam drug therapies. A second group of patients attending the above clinic (n = 30) were asked to fill out a hospital anxiety and depression assessment form in an attempt to correlate treatment success with underlying psychological status. Results: A total of 71.4 per cent of patients treated with clonazepam had partial or complete resolution of their oral symptoms, while 55.1 per cent of patients treated with diazepam had improvement of their oral symptoms. There was no correlation between underlying anxiety or depression and efficacy of benzodiazepine medication. Conclusions: A greater percentage of patients taking clonazepam reported either partial or complete relief of symptoms compared to diazepam. However, the differences were not statistically significant. There was no correlation found between underlying psychopathology and treatment success with benzodiazepines. 相似文献
82.
Daw NC Neel MD Rao BN Billups CA Wu J Jenkins JJ Quintana J Luchtman-Jones L Villarroel M Santana VM 《Cancer》2011,117(12):2770-2778
BACKGROUND:
The standard treatment of osteosarcoma includes cisplatin and high‐dose methotrexate (HDMTX); both agents exert significant toxicity, and HDMTX requires complex pharmacokinetic monitoring and leucovorin rescue. In the previous OS91 trial, the treatment of localized disease with carboplatin, ifosfamide, doxorubicin, and HDMTX yielded outcomes comparable to those of cisplatin‐based regimens and caused less toxicity. To build on this experience, the authors conducted a multi‐institutional trial (OS99) that evaluated the efficacy of carboplatin, ifosfamide, and doxorubicin without HDMTX in patients with newly diagnosed, localized, resectable osteosarcoma.METHODS:
Treatment was comprised of 12 cycles of chemotherapy administered over 35 weeks: 3 cycles of carboplatin (dose targeted to area under the concentration‐time curve of 8 mg/mL × min on Day 1) and ifosfamide (at a dose of 2.65 g/m2 daily ×3 days) and 1 cycle of doxorubicin (at a dose of 25 mg/m2 daily ×3 days) before surgical resection, followed by 2 additional cycles of the combination of carboplatin and ifosfamide and 3 cycles each of doxorubicin (25 mg/m2 daily ×2 days) combined with ifosfamide or carboplatin.RESULTS:
A total of 72 eligible patients (median age, 13.4 years) were enrolled between May 1999 and May 2006. Forty of the 66 (60.6%) evaluable patients had good histologic responses (>90% tumor necrosis) to preoperative chemotherapy. The estimated 5‐year event‐free survival rate was 66.7% ± 7.0% for the OS99 trial compared with 66.0% ± 6.8% for the OS91 trial (P = .98). The estimated 5‐year survival rate was 78.9% ± 6.3% for the OS99 trial and 74.5% ± 6.3% for the OS91 trial (P = .40).CONCLUSIONS:
The regimen used in the OS99 trial was found to produce outcomes comparable to those of cisplatin‐containing or HDMTX‐containing regimens. This therapy offers a good alternative for patients, particularly those who demonstrate an intolerance of HDMTX, and for institutions that cannot provide pharmacokinetic monitoring for MTX. Cancer 2011. © 2011 American Cancer Society. 相似文献83.
Cox AO Daw RC Mason MD Grabenauer M Pande PG Davis KH Wiley JL Stout PR Thomas BF Huffman JW 《Journal of analytical toxicology》2012,36(5):293-302
The increasing prevalence and use of herbal mixtures containing synthetic cannabinoids presents a growing public health concern and legal challenge for society. In contrast to the plant-derived cannabinoids in medical marijuana and other cannabinoid-based therapeutics, the commonly encountered synthetic cannabinoids in these mendaciously labeled products constitute a structurally diverse set of compounds of relatively unknown pharmacology and toxicology. Indeed, the use of these substances has been associated with an alarming number of hospitalizations and emergency room visits. Moreover, there are already several hundred known cannabinoid agonist compounds that could potentially be used for illicit purposes, posing an additional challenge for public health professionals and law enforcement efforts, which often require the detection and identification of the active ingredients for effective treatment or prosecution. A solid-phase microextraction headspace gas chromatography-mass spectrometry method is shown here to allow for rapid and reliable detection and structural identification of many of the synthetic cannabinoid compounds that are currently or could potentially be used in herbal smoking mixtures. This approach provides accelerated analysis and results that distinguish between structural analogs within several classes of cannabinoid compounds, including positional isomers. The analytical results confirm the continued manufacture and distribution of herbal materials with synthetic cannabinoids and provide insight into the manipulation of these products to avoid legal constraints and prosecution. 相似文献
84.
Although the human amygdala and striatum have both been implicated in associative learning, only the striatum's contribution has been consistently computationally characterized. Using a reversal learning task, we found that amygdala blood oxygen level-dependent activity tracked associability as estimated by a computational model, and dissociated it from the striatal representation of reinforcement prediction error. These results extend the computational learning approach from striatum to amygdala, demonstrating their complementary roles in aversive learning. 相似文献
85.
86.
Shankar A Hall GW Gorde-Grosjean S Hasenclever D Leblanc T Hayward J Lambilliotte A Daw S Perel Y McCarthy K Lejars O Coulomb A Oberlin WO Wallace WH Landman-Parker J 《European journal of cancer (Oxford, England : 1990)》2012,48(11):1700-1706
PurposeTo examine whether three cycles of a low-intensity chemotherapy consisting of cyclophosphamide [500 mg/m2 – day 1], vinblastine [6 mg/m2 – days 1 and 8] and prednisolone [40 mg/m2 – days 1–7] (CVP) is safe and therapeutically effective in children and adolescents with early stage nodular lymphocyte predominant Hodgkin lymphoma [nLPHL].Patients and methodsFifty-five children and adolescents with early stage nLPHL [median age 13 years, range 4–17 years] diagnosed between June 2005 and October 2010 in the UK and France are the subjects of this report. Staging investigations included conventional cross sectional as well as 18 fluro-deoxyglucose [FDG] PET imaging. Histology was confirmed as nLPHL by an expert pathology panel.ResultsOf the 45 patients, who received CVP as first line treatment, 36 [80%, 95% Confidence Interval [CI]: (68; 92)] either achieved a complete remission [CR] or CR unconfirmed [CRu], the remaining nine patients achieved a partial response. All nine subsequently achieved CR with salvage chemotherapy [n = 7] or radiotherapy [n = 2]. Ten patients received CVP at relapse after primary treatment that consisted of surgery alone and all achieved CR. To date, only three patients have relapsed after CVP chemotherapy and all had received CVP as first line treatment at initial diagnosis. The 40-month freedom from treatment failure and overall survival for the entire cohort were 75.4% (SE ± 6%) and 100%, respectively. No significant early toxicity was observed.ConclusionsOur results show that CVP is an effective chemotherapy regimen in children and adolescents with early stage nLPHL that is well tolerated with minimal acute toxicity. 相似文献
87.
88.
A. K. M. Moinul Hossain Barry L. Shulkin Michael J. Gelfand Humayun Bashir Najat C. Daw Susan E. Sharp Helen R. Nadel Jeffrey S. Dome 《European journal of nuclear medicine and molecular imaging》2010,37(7):1300-1308
Purpose
The purpose of this analysis was to evaluate the utility of FDG PET/CT scanning in patients with Wilms’ tumors. 相似文献89.
90.